SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI)
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
This study will the safety of a 96-hour intravenous vitamin C infusion protocol (50 mg/kg
every 6 hours) in patients with hypoxemia and suspected COVID-19.